spacer
The Healthcare Sales & Marketing Network celebrates 27 years serving the medical sales & marketing community.Connecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product LinesConnecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product Lines

Searching News Database:  PTCA 

 HSMN NewsFeed - 11 Jan 2023
MedAlliance SELUTION SLR is the first DEB to receive coronary de novo IDE approval, its fourth FDA IDE DEB Approval
Devices Interventional Cardiology FDA
 HSMN NewsFeed - 23 Sep 2020
OrbusNeich(R) Announces China Approval for COMBO(R) Coronary Stent
Devices Interventional Cardiology Regulatory
 HSMN NewsFeed - 30 Jun 2020
MedAlliance Gains CE Mark Approval for Coronary SELUTION SLR(TM) Sirolimus Drug Eluting Balloon
Devices Interventional Cardiology Regulatory
 HSMN NewsFeed - 6 Aug 2019
CeloNova Announces Appointment of New President and CEO
Devices Interventional Cardiology Personnel
 HSMN NewsFeed - 20 Dec 2016
TriReme Medical Signs Agreement With HealthTrust To Broaden Hospital Access To Chocolate(R) And Glider(TM) Product Lines
Devices Interventional Cardiology Group Purchasing
 HSMN NewsFeed - 2 Nov 2016
Cardinal Health Announces New Strategic Distribution Agreements to Expand Cordis' Cardiovascular Product Offerings in Asia Pacific
Devices Cardiology Distribution
 HSMN NewsFeed - 25 Jul 2016
QT Vascular Announces Federal Circuit Reversal of Adverse AngioScore / Spectranetics Judgment
Devices Interventional Cardiology Litigation
 HSMN NewsFeed - 7 Jul 2016
QT Vascular Receives CE Mark Clearance for Chocolate Heart(TM), a Novel Drug-Coated Coronary Balloon
Devices Interventional Cardiology Regulatory
 HSMN NewsFeed - 7 Jan 2016
QT Vascular Announces Clinical Outcomes of Its Chocolate Heart Drug Coated Coronary Balloon
Devices Interventional Cardiology
 HSMN NewsFeed - 30 Sep 2015
QT Vascular Announces Positive Outcome in Spectranetics/AngioScore Patent Trial
Devices Interventional Litigation
 HSMN NewsFeed - 9 Jul 2015
The Medicines Company Authorizes Generic Launch of ANGIOMAX(R) (bivalirudin)
Biopharmaceuticals Generics Product Launch
 HSMN NewsFeed - 9 Jun 2015
CMS Further Improves Reimbursement for Lutonix DCB for Outpatient Use
Devices Interventional Reimbursement
 HSMN NewsFeed - 18 Dec 2014
The Medicines Company and SciClone Pharmaceuticals Establish Strategic Partnership for Two Cardiovascular Products in China
Biopharmaceuticals Cardiology Licensing
 HSMN NewsFeed - 19 Aug 2014
Boston Scientific and ASAHI INTECC Announce Joint Development and Manufacturing Programs
Devices Interventional Cardiology
 HSMN NewsFeed - 24 Jul 2014
Boston Scientific Receives CE Mark For Agent(TM) Drug-Coated Balloon
Devices Interventional Cardiology Regulatory
 HSMN NewsFeed - 5 Jun 2014
QT Vascular Announces FDA Clearance of Chocolate PTCA Balloon Catheter
Devices Interventional Cardiology FDA
 HSMN NewsFeed - 3 Dec 2013
Physicians Throughout U.S. Using Cardiovascular Systems’ New Technology to Treat Coronary Artery Disease
Devices Interventional Cardiology Product Launch
 HSMN NewsFeed - 30 Oct 2013
The Medicines Company's EUROMAX Trial of Angiox(R) (Bivalirudin) in Heart Attack Meets All Prespecified Endpoints
Biopharmaceuticals Cardiology
 HSMN NewsFeed - 22 Oct 2013
Cardiovascular Systems, Inc. Receives Coronary FDA Approval
Devices Interventional Cardiology FDA Product Launch
 HSMN NewsFeed - 9 Oct 2013
First Patient Enrolled in Phase III Trial Evaluating The Medicines Company's Angiomax(R) (Bivalirudin) in Patients Undergoing Peripheral Endovascular Procedures
Biopharmaceuticals Interventional
 HSMN NewsFeed - 22 Apr 2013
TriReme Receives Shonin Approval to Market Glider(TM) PTCA Catheter
Devices Interventional Cardiology Distribution Regulatory
 HSMN NewsFeed - 28 Sep 2012
Boston Scientific Launches Emerge(TM) PTCA Balloon Dilatation Catheter in the U.S.
Devices Interventional Cardiology FDA
 HSMN NewsFeed - 28 Aug 2012
Latest European Heart Attack Treatment Guidelines Recommend Angiomax(R)/Angiox(R) (Bivalirudin) Over Heparin
Biopharmaceuticals Cardiology
 HSMN NewsFeed - 16 Jul 2012
TriReme Receives FDA Approval for Expanded Matrix of Novel Glider(TM) PTCA Balloon Catheter
Devices Interventional Cardiology FDA
 HSMN NewsFeed - 23 May 2012
TriReme Medical, Inc. Receives FDA Approval for Glider(TM) PTCA Catheter
Devices Interventional Cardiology FDA
 HSMN NewsFeed - 24 Apr 2012
Boston Scientific Announces CE Mark and European Launch of Emerge(TM) PTCA Dilatation Catheter
Devices Interventional Cardiology Regulatory
 HSMN NewsFeed - 31 Aug 2011
DSM ComfortCoat(R) Hydrophilic Coating Enhances the Capabilities Of PendraCare PRIMUM Guiding Catheters
Devices Interventional
 HSMN NewsFeed - 16 May 2011
BridgePoint Medical Announced 510(k) Clearance for an Expanded Indication to Treat Coronary Chronic Total Occlusions
Devices Interventional Cardiology FDA
 HSMN NewsFeed - 16 May 2011
Cordis Launching Two New Products at EuroPCR Congress
Devices Interventional Cardiology
 HSMN NewsFeed - 20 Apr 2011
AngioScore Announces Completion of $12 Million Financing
Devices Interventional Cardiology Venture Capital
 HSMN NewsFeed - 30 Dec 2010
AngioScore Incorporated, Announces Worldwide Voluntary Field Removal of the AngioSculpt(R) PTA Scoring Balloon Catheter, 0.018” OTW, Balloon Sizes: 4.0x20mm, 5.0x20mm, and 6.0x20mm
Devices Interventional Cardiology Product Recall
 HSMN NewsFeed - 13 Aug 2010
First Patient Treated with Drug Eluting Absorbable Metal Scaffold in the BIOTRONIK "BIOSOLVE-I" Clinical Study
Devices Interventional Cardiology
 HSMN NewsFeed - 25 May 2010
Boston Scientific Announces CE Mark and FDA Approval of NC Quantum Apex Balloon Catheter
Devices FDA Interventional Cardiology Regulatory
 HSMN NewsFeed - 27 Apr 2010
Volcano Announces Distribution Agreement With AngioScore for the AngioSculpt(R) PTCA Scoring Balloon Catheter in Japan
Devices Interventional Cardiology Distribution
 HSMN NewsFeed - 18 Jan 2010
St. Jude Medical Announces Approval and Launch of Neurostimulation System in Japan
Devices Neurology Regulatory
 HSMN NewsFeed - 19 Jun 2009
FDA Grants The Medicines Company Pediatric Exclusivity for Angiomax(R)
Biopharmaceuticals Cardiology
 HSMN NewsFeed - 19 May 2009
Invatec Officially Launches Coronary Drug-Eluting Balloon Platform IN.PACT Falcon at EuroPCR
Devices Interventional Cardiology
 HSMN NewsFeed - 26 Mar 2009
Cordis Celebrates 50 Years of Transforming Cardiovascular Care
Devices Interventional Cardiology
 HSMN NewsFeed - 20 Jan 2009
Volcano Highlights Commitment, Market Acceptance of FFR Product Line
Devices Interventional Cardiology
 HSMN NewsFeed - 10 Nov 2008
FDA Approves Boston Scientific's Apex(TM) PTCA Dilatation Catheter
Devices Interventional Cardiology FDA
 HSMN NewsFeed - 15 Oct 2008
Volcano Corporation Announces Launch of PrimeWire(TM) Pressure Guidewire and s5-FFR Option for Existing Fleet of s5 IVUS Consoles
Devices Interventional Cardiology
 HSMN NewsFeed - 3 Sep 2008
New Analysis From HORIZONS-AMI Shows Major Bleeding Has a Significant Impact and Contributes to 30-Day Mortality Following Angioplasty in Severe Heart Attack Patients
Biopharmaceuticals Cardiology
 HSMN NewsFeed - 2 Sep 2008
New Data Shows Anticlotting Medicine, AGGRASTAT(R), Lowers Incidence of Heart Attack, in Patients Who Respond Poorly to Aspirin or Clopidogrel, after Elective Coronary Angioplasty
Biopharmaceuticals Cardiology
 HSMN NewsFeed - 26 Aug 2008
ACUITY 1-Year Sub-Analysis Published in Journal of the American College of Cardiology
Biopharmaceuticals Cardiology
 HSMN NewsFeed - 10 Jul 2008
AngioScore Launches New Longer and Larger AngioSculpt(R) Devices for Treatment of Peripheral Artery Disease
Devices Interventional
 HSMN NewsFeed - 4 Jun 2008
AngioScore Announces Initiation of Enrollment in Multi-Center Coronary Artery Bifurcation Trial
Devices Interventional Cardiology
 HSMN NewsFeed - 28 May 2008
The Medicines Company Receives FDA Review Letter for Angiomax Supplemental Filing
Biopharmaceuticals Cardiology FDA
 HSMN NewsFeed - 22 May 2008
Results Published in New England Journal of Medicine Show Angiomax Improved Net Clinical Outcomes and Resulted in Improved Survival Rates in the Most Severe Heart Attack Patients
Biopharmaceuticals Cardiology
 HSMN NewsFeed - 1 May 2008
AngioScore Receives FDA Clearance to Market AngioSculpt PTA Scoring Balloon Catheter for Additional Peripheral Indications
Devices Interventional FDA
 HSMN NewsFeed - 7 Apr 2008
OrbusNeich Receives CE Mark Approval for Sapphire(TM) 1.25MM PTCA Dilatation Catheter
Devices Interventional Cardiology
 HSMN NewsFeed - 29 Mar 2008
Angiomax Demonstrated Improved Outcomes in Acute Heart Attack Patients Undergoing Primary Angioplasty Independent of Individual Risk Factors
Biopharmaceuticals Interventional Cardiology
 HSMN NewsFeed - 30 Jan 2008
Iroko Pharmaceuticals Acquires Rights to Cardiovascular Product from Merck & Co., Inc.
Biopharmaceuticals Cardiology Acquisitions
 HSMN NewsFeed - 29 Jan 2008
The Medicines Company's Angiox(R) Receives European Authorization for Expanded Use in Patients with Acute Coronary Syndromes (ACS)
Biopharmaceuticals Cardiology Regulatory
 HSMN NewsFeed - 4 Dec 2007
Journal of the American Medical Association (JAMA) Publishes One-Year ACUITY Trial Results
Biopharmaceuticals Cardiology
 HSMN NewsFeed - 24 Oct 2007
Angiomax(R) / Angiox(R) (bivalirudin) Significantly Improved Net Outcomes in Heart Attack Patients
Biopharmaceuticals Cardiology
 HSMN NewsFeed - 25 Sep 2007
Cordis Corporation Introduces FIRE STAR(TM) Rx PTCA Dilatation Catheter and DURA STAR(TM) Rx PTCA Dilatation Catheter
Devices Interventional Cardiology
 HSMN NewsFeed - 24 Sep 2007
FDA Accepts sNDA for Expanded Use of Angiomax(R) (bivalirudin)
Biopharmaceuticals Cardiology FDA
 HSMN NewsFeed - 12 Sep 2007
Proven Terumo Coronary Guidewire Technology Is Now Available in the United States
Devices Interventional Cardiology
 HSMN NewsFeed - 2 Sep 2007
Angiox(R) (Bivalirudin) Alone Reduced Early Bleeding and Resulted in Similar One-Year Mortality Compared to Heparins Plus GP IIb/IIIa Combination Therapy in ACS Patients Undergoing Angioplasty
Biopharmaceuticals Cardiology
 HSMN NewsFeed - 7 Aug 2007
The Medicines Company Submits Angiomax(R) (Bivalirudin) sNDA to Expand Label to Include ACUITY Data
Biopharmaceuticals Cardiology
 HSMN NewsFeed - 27 Jul 2007
Positive Aggrastat(R) Results Versus Integrilin(R) Featured in American Heart Journal
Biopharmaceuticals Interventional Cardiology
 HSMN NewsFeed - 2 Jul 2007
The Medicines Company Reacquires Angiox(R) (Bivalirudin) Rights in Europe from Nycomed
Biopharmaceuticals Cardiology
 HSMN NewsFeed - 21 May 2007
OrbusNeich Receives CE Mark Approval for Blazer(TM) Cobalt Chromium Stent, Sapphire(TM) PTCA Dilatation Catheter, Lumina(TM) Guiding Catheter
Devices Regulatory Interventional Cardiology
 HSMN NewsFeed - 26 Mar 2007
ACUITY One-Year Findings Meet All Primary Endpoints in Favor of Angiomax(R) (Bivalirudin) Alone Treatment Group
Biopharmaceuticals Cardiology
 HSMN NewsFeed - 29 Jan 2007
Radi Medical Systems Announces the First Shipment of the Next Generation Pressure Wire, PressureWire(R) Certus
Devices Interventional Cardiology
 HSMN NewsFeed - 1 Dec 2006
Micrus Endovascular Acquires Catheter Technology Company VasCon LLC
Devices Mergers & Acquisitions
 HSMN NewsFeed - 22 Nov 2006
The New England Journal of Medicine Publishes Angiomax(R) (Bivalirudin) ACUITY Trial Results
Biopharmaceuticals Cardiology
 HSMN NewsFeed - 21 Sep 2006
Cordis Corporation and Brivant Limited Sign Distribution Agreement for Three Interventional Products
Devices Interventional Cardiology Distribution
 HSMN NewsFeed - 21 Sep 2006
MIV Therapeutics Appoints Montreal Heart Institute Interventional Cardiologist Dr. Raoul Bonan to Guide Clinical Programs
Devices Personnel
 HSMN NewsFeed - 19 Sep 2006
CardioVascular Technologies, Inc. Announces Patent Notice of Allowance for its Rapid Exchange (RX) Catheter Platform with Stent Deployment Features Technology
Devices Interventional Cardiology
 HSMN NewsFeed - 28 Jun 2006
Cordis Corporation and ClearStream Technologies Group, plc, Sign Distribution Agreement for New Balloon Dilation Catheter
Devices Distribution Interventional Cardiology
 HSMN NewsFeed - 26 Jun 2006
ev3 Receives FDA Clearance for SpideRX(TM) Embolic Protection Device for Saphenous Vein Graft Angioplasty
Devices Interventional FDA
Return to NewsFeed  

 Additional items found! 58

Members: click here for search results from The HSMN Archive (password required)
Members Archive contains 58 additional stories matching:
PTCA
(Password required)
FindReps - Find Great Medical Independent Sales Reps without recruiter fees.
FindReps - available on the Apple App Store for iPhone and iPad.